The High-Resolution Electron Microscopy Facility (HREMF), located t the R.E. """"""""Bob"""""""" Smith Research Building (SRB), is under the direction of Dr. Corazon D. Bucana. The facility houses a Hitachi S520 (>10 years old) scanning electron microscope (SEM) equipped with secondary back-scatter electron detectors, a Micro G isolation table, and a Nova Ultramicrotome and Ultrastainer, and other accessories needed to prepare samples for either SEM or TEM. It also contains ancillary equipment needed for the production of black and white photographs. A Pentium computer with network capabilities and a flatbed scanner allows for electronic transfer of data (images). The well-equipped and staffed facility has allowed the institution to utilize high-resolution electron microscopy without extensive duplication of equipment and services. The facility houses the only SEM on campus, and the other TEMs, located in the Department of Pathology, are dedicated to service and diagnostic purposed with little time for research application. Among the services provided by the facility are: (a) consultation and assistance in the design of experiments to utilize SEM and TEM, (b) conventional processing of samples for SEM and TEM, (c) research and development of novel techniques to meet the demands of individual research projects, and (d) interpretation of data and recommendation for subsequent and future experiments. Further information regarding the facility and availability to investigators can be accessed from M.D. Anderson Home page on the World Wide Web. The HREMF has been operation at its present site since January 1997. The major goal of this facility is to continue to provide a resource to the scientific community at M.D. Anderson Cancer for high-resolution imaging of cells, tissues, organs, or polymers containing anti-cancer agents. Since 1995, 14 departments have utilized both SEM and TEM in their research. The corroborative techniques for light microscopy, fluorescence microscopy, SEM and TEM are often required independently or sequentially. Demand for ultrastructural analysis of apoptosis at both the SEM and TEM levels and the resurgence of morphological characterization of cells, organs, and embryos following genetic manipulation has raised demand for both SEM and TEM.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA016672-25S1
Application #
6347266
Study Section
Project Start
2000-08-30
Project End
2001-06-30
Budget Start
Budget End
Support Year
25
Fiscal Year
2000
Total Cost
$254,104
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Viswanathan, Chitra; Faria, Silvana; Devine, Catherine et al. (2018) [18F]-2-Fluoro-2-Deoxy-D-glucose-PET Assessment of Cervical Cancer. PET Clin 13:165-177
Debnam, James M; Chi, Tzehping L; Ketonen, Leena et al. (2018) Superiority of Multidetector Computed Tomography With 3-Dimensional Volume Rendering Over Plain Radiography in the Assessment of Spinal Surgical Instrumentation Complications in Patients With Cancer. J Comput Assist Tomogr :
Patel, V K; Lamothe, B; Ayres, M L et al. (2018) Pharmacodynamics and proteomic analysis of acalabrutinib therapy: similarity of on-target effects to ibrutinib and rationale for combination therapy. Leukemia 32:920-930
Ravandi, Farhad; Ritchie, Ellen K; Sayar, Hamid et al. (2018) Phase 3 results for vosaroxin/cytarabine in the subset of patients ?60 years old with refractory/early relapsed acute myeloid leukemia. Haematologica 103:e514-e518
Assi, Rita; Kantarjian, Hagop M; Kadia, Tapan M et al. (2018) Final results of a phase 2, open-label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome. Cancer 124:2758-2765
Yam, Clinton; Murthy, Rashmi K; Valero, Vicente et al. (2018) A phase II study of tipifarnib and gemcitabine in metastatic breast cancer. Invest New Drugs 36:299-306
Lacourt, Tamara E; Vichaya, Elisabeth G; Escalante, Carmen et al. (2018) An effort expenditure perspective on cancer-related fatigue. Psychoneuroendocrinology 96:109-117
Ni, Haiwen; Shirazi, Fazal; Baladandayuthapani, Veerabhadran et al. (2018) Targeting Myddosome Signaling in Waldenström's Macroglobulinemia with the Interleukin-1 Receptor-Associated Kinase 1/4 Inhibitor R191. Clin Cancer Res 24:6408-6420
Neelapu, Sattva S; Tummala, Sudhakar; Kebriaei, Partow et al. (2018) Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'. Nat Rev Clin Oncol 15:218
Cortes, Jorge; Tamura, Kenji; DeAngelo, Daniel J et al. (2018) Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers. Br J Cancer 118:1425-1433

Showing the most recent 10 out of 12418 publications